Renal Cell Carcinoma Clinical Trials in Beijing, Beijing Municipality

10 recruitingBeijing, Beijing Municipality, China

Showing 110 of 10 trials

Recruiting

Validation of RCC Predicting Model With Emulated-target Trial

Prognostic Cancer ModelRenal Cell Carcinoma (RCC)Prognosis+4 more
Peking University Third Hospital4,700 enrolled1 locationNCT07117227
Recruiting
Phase 1Phase 2

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Hepatocellular CarcinomaSolid TumorsNon-small Cell Lung Cancer+1 more
3D Medicines (Sichuan) Co., Ltd.170 enrolled23 locationsNCT05024214
Recruiting
Phase 1Phase 2

Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Other Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom

Advanced Renal Cell Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.139 enrolled1 locationNCT07239596
Recruiting
Phase 1

A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors

MelanomaNon-small Cell Lung CancerRenal Cell Carcinoma
Shanghai Henlius Biotech174 enrolled69 locationsNCT07160335
Recruiting
Phase 1Phase 2

Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma

Advanced Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.104 enrolled1 locationNCT07097935
Recruiting
Phase 2

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

Clear Cell Renal Cell Carcinoma
Peking Union Medical College Hospital40 enrolled1 locationNCT06613269
Recruiting
Phase 1

A Study of HS-10516 in Patients With VHL Syndrome Associated Tumors

Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma
Jiangsu Hansoh Pharmaceutical Co., Ltd.60 enrolled1 locationNCT06553339
Recruiting

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Renal Cell CarcinomaVHL Syndrome
Peking University First Hospital300 enrolled1 locationNCT06391879
Recruiting

Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis

Breast CancerLiver CancerColorectal, Cancer+10 more
Beijing Friendship Hospital2,700 enrolled4 locationsNCT06363123
Recruiting

The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy

Liver CancerPancreatic CancerLung Cancer+1 more
Peking University Third Hospital57 enrolled1 locationNCT06342323